AKT1 and hepatocellular carcinoma: For instance, the combined treatment using regorafenib and chemical compounds, such as the chlorogenic acid (CGA) and cisplatin, enhanced its cytotoxicity by suppressing the PI3K/Akt/mTOR pathway in the HCC cells [45,46].